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AbstrAct 
Objectives: To undertake a cross-cultural adaptation
and validation of the educational needs assessment tool
(ENAT) into Portuguese. 
Methods: The first phase of this research (cross-cultu-
ral adaptation) utilised a well-established translation
method comprising five sequential steps: forward-
-translation, synthesis of translations, back-translation,
expert committee and field-testing of the adapted ver-
sion. The second phase involved collecting data from
123 patients and subjecting them to Rasch analysis for
validity testing including cross-cultural invariance. 
Results: The translation and field-testing phase went
smoothly giving rise to minor adjustments in the phra-
sing of some items. The preliminary analysis of the 39
items, revealed some deviations from the model with
the overall item-person interaction fit statistics 2(df) =
56.025 (39), p = 0.038. Significant item-item correla-
tions caused artificial inflation of the internal consis-
tency, therefore violating the model assumption of lo-
cal independence of items. To correct this, all locally
dependent items were then grouped into their respec-
tive domains, creating a 7 testlet-scale which demons-
trated a good fit to the Rasch model, 2(df) = 2.625 (7),
p = 0.917 and internal consistency PSI = 0.975. Ana-
lysis of the pooled (Portuguese and the English) data re-
vealed cross-cultural DIF, requiring adjustments in two
testlets: ‘treatments’ and ‘support’ which ensured cross-
-cultural equivalence. 
Conclusions: This study confirms the Portuguese
ENAT is a robust unidimensional tool with which to
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assess the educational needs of Portuguese people with
RA. Cross-cultural adjustments are required only if the
data from Portugal and the UK are pooled or compa-
red. The tool is now available for use in clinical practi-
ce and research.
Keywords: Patient Education; Self-management;
Rheumatoid Arthritis; Cross-cultural adaptation; Tool
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IntroductIon
People with arthritis want to know more about their
arthritis and the best way to manage it in their daily li-
ves1,2. In the face of well-entrenched arthritis myths and
insufficient social marketing or public awareness cam-
paigns, patient education (PE) and self-management
programs are important, particularly given the subs-
tantial and increasing burden of arthritis on health-care
resources and society3.
PE plays a particularly important role in the mana-
gement of the patients with Rheumatoid Arthritis (RA)4
and usually begins when a person is first diagnosed. It
can be both an illuminating and frustrating process, not
only for the patients but also for their family, friends, co-
workers and employers, and Health Professionals.
A Cochrane review in 2003 cast some doubts on the
effectiveness of PE on health status in RA5. However,
most studies in the review did not take into account
the appropriateness of interventions at different stages
of the patient’s adjustment to their RA, which is unsur-
prising as a literature search found no tool that could
be used for this purpose.
PE is a multi-dimensional process encompassing pa-
tients’ beliefs, provider factors, and content and deli-
very methods, all of which complicate the choice of
outcome measures and the assessment of effects. Over
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the past 10 years PE has advanced and newer studies
suggest that PE is based on patients’ needs and indivi-
dual learning capabilities6,7. This view has been reflec-
ted in recent RCTs which have been more specific in
their methods and some long-term effects have been
found8.
The Educational Needs Assessment Tool (ENAT)9
was developed as a quick and simple method of col-
lecting data that ensures that patient education is rele-
vant, appropriate and timely for the individual. The
tool is a self-completed questionnaire comprising 39
items in 7 domains:
1. Managing pain – individual medications, using
heat/cold, distraction, relaxation, exercise, acu-
puncture, hydrotherapy.
2..Movement – practical devices, lifting, energy con-
servation, rest/sleep, joint protection.
3. Feelings – dealing with stress, moods/depression, fa-
tigue.
4. Arthritis process – cause, type of arthritis, heredity,
treatments, disability, future.
5. Treatments - need for medication, how to take it, side
effects, reason for blood tests, X-rays, surgery, ap-
pliances.
6. Self-help measures – alternative therapy, vitamins,
what to avoid doing, home exercises, how much
exercise, when to contact a doctor or a nurse.
7. Support systems - helpful organisations, financial
help, coping groups, getting the most out of con-
sultations.
Patients score the items by ticking 5-point Likert
scales ranging from ’not at all important‘ to ’extreme-
ly important‘. There is also a front sheet for collecting
demographic data and a space for patients to add any
topics/questions that are not included in the ques-
tionnaire. It takes the patient only a few minutes to
complete and provides data that enables the health
professional to provide timely and meaningful educa-
tion and information that is pertinent to each indivi-
dual patient.
The ENAT was developed in the United Kingdom
and was shown to be reliable (test/retest: ICC=0.823;
p<0.01), valid and acceptable to patients who also
commented on its ease of completion9,10. Rasch analy-
sis of the English version demonstrated its unidimen-
sionality, reliability and robustness – working in the
same way across different patient groups10,11. The
ENAT’s measurement properties suggest that it can also
be used as a research tool to accurately assess educa-
tional interventions12-14. The aim of this study was to
translate the ENAT into Portuguese (PortENAT) and to
assess its cross-cultural validity in RA by using Rasch
analysis.
Methods 
PArtIcIPAnts 
Participants were patients with RA attending the Rheu-
matology Department Outpatients Clinic at Coimbra
University Hospital, in Coimbra, Portugal. The inclu-
sion criteria were age >18 years, diagnosis of RA and
ability to complete the questionnaire unaided. Exclu-
sion criteria were (i) having any other rheumatic di-
sease such as systemic lupus erythematosus, systemic
sclerosis, psoriatic arthritis, ankylosing spondylitis and
osteoarthritis, (ii) inability to read or write and (iii) tho-
se unwilling to participate. Participation was volunta-
ry and ethical approval was obtained from Coimbra
University Hospital Ethics Committee.
Procedure 
The study design was cross-sectional and followed
standardised guidelines for cross-cultural adaptation
and validation of patient-reported outcome measu-
res15,16. It was undertaken in two phases: (i) cross-cul-
tural adaptation into Portuguese and (ii) validation of
the adapted ENAT (PortENAT) using Rasch analysis.
PhAse 1: cross-culturAl AdAPtAtIon Into
Portuguese: 
The ENAT was translated into Portuguese using an es-
tablished process for cross-cultural adaptation of pa-
tient reported outcome measures15. It comprises five
stages: initial translation, synthesis of these translations,
back translation, expert committee assessment and
field-testing.
INITIAL TRANSLATION
The first stage in adaptation was a ‘forward translation’
from English (source language) into Portuguese (the tar-
get language), carried out by two independent transla-
tors whose mother tongue was Portuguese. The first
translator was a professional bilingual translator (FA)
and the second was a bilingual lay person (CA). The
two translations were then compared, and discrepancies
such as ambiguous wording in the original language, or
discrepancies in how a word is translated were identi-
fied. Poor wording choices were discussed and resol-
ved. The two translators each produced a written report
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(T1 and T2)15 of their translation. Comments were in-
cluded to highlight challenging phrases or uncertain-
ties along with the rationale for final choices.
SYNTHESIS OF THESE TRANSLATIONS
To produce a synthesis of the two translations, a third,
unbiased person was added to the team (MP). The role
of this person was to serve as a mediator in the dis-
cussion of translation differences, and to produce a
written documentation of the process. Working from
the original questionnaire, as well as from the first (T1)
and the second translator’s (T2) version, a synthesis of
these translations was produced, resulting in one com-
mon translation (T-12). A written report documenting
the process, the issues addressed and how they were
resolved was completed.
BACK-TRANSLATION
Working from the T-12 version of the ENAT, and to-
tally blind to the original version, the questionnaire
was then translated back into English by two bilingual
back-translators (FA and CA), with English as their
mother tongue, producing translations BT1 and BT2.
This is a process of validity checking to make sure the
translated version accurately reflects the item content
of the original version.
EXPERT COMMITTEE
The composition of the expert committee included a
methodologist (HJ), health professionals (MA), all the
translators (both forward and backward) and the trans-
lation synthesis recorder. The original developer of the
questionnaire was also included. The expert commit-
tee consolidated all the versions and components of
the questionnaire and all translated versions (T1, T2,
T12, BT1, BT2), and a final version of the ENAT was
produced for field testing.
TEST OF THE ADAPTED VERSION
The field test of the adapted ENAT comprised 30 RA
patients who completed the questionnaire unaided.
They were then interviewed to probe what they
thought was meant by each questionnaire item and
their response. Both the meaning of the items and res-
ponses were explored. This ensured that the adapted
version retained its equivalence. The distribution of
responses was examined to look for a high proportion
of missing items or single responses. Once completed,
the questionnaires were summarised and analysed des-
criptively using the IBM SPSS software version 1917.
PhAse 2: VAlIdAtIon of the AdAPted enAt by
rAsch AnAlysIs
The final translated version of the ENAT, the Por tENAT
was then completed by a consecutive sample of 123
patients with RA fulfilling the inclusion criteria. They
were asked to return it at the end of the clinic consul-
tation. The resultant questionnaires were entered into
a database and prepared for analysis.
dAtA AnAlysIs
The measurement properties of the PortENAT were
tested by Rasch analysis using the Masters Partial Cre-
dit Model parameterisation18 in RUMM202019 softwa-
re. Rasch analysis is a mathematical modelling techni-
que used to assess properties of outcome measures
against a measurement model developed by the Da-
nish mathematician Georg Rasch20. The observed data
from the adapted PortENAT were measured against the
model to assess their goodness of fit, with ‘good fit’ in-
dicating a criterion-related construct validity, reliabi-
lity and statistical sufficiency21-23. For the model fit, the
observed value for the residuals of each item is expec-
ted to lie within lie within ±2.5, and to have a mean of
zero and standard deviation of one. The overall fit sta-
tistics are given in terms of a c2 (item-person) interac-
tion and its associated probability, which is expected
to be non-significant (i.e. not deviating from the Rasch
model). A more detailed description of the Rasch ana-
lysis approach, its use in rheumatology and the inter-
pretation of fit statistics is given elsewhere24.
For this analysis, the data from PortENAT were as-
sessed for threshold ordering, individual item-fit and
the assumption of local dependence of items. In addi-
tion, we tested the overall (item-person interaction)
fit, internal consistency and the strict assessment of
unidimensionality. Lastly, invariance to age, gender, di-
sease duration and education background were asses-
sed. Local dependency was defined as item-item cor-
relation of greater than ±0.325. The locally dependent
items were subsequently combined into subscales and
each subscale treated as a ’testlet‘, which is defined as
a subset of items that is treated as a measurement unit
in test construction, administration and/or scoring26.
Strict unidimensionality of the PortENAT was asses-
sed by using the independent t-test method suggested
by Smith27. The internal reliability was reported using
Person Separation Index (PSI), which provides the es-
timate of the internal consistency of the scale.24 In or-
der to avoid type I errors resulting from to multiple
testing28 all p-values for fit statistics were Bonferroni-
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CROSS-CULTURAL VALIDATION PHASE
Assessment of the response structure in the 39 items,
revealed ordered thresholds in most items, indicating
that the 5-point category response structure (not at all
important, a little important, fairly important, very im-
portant and extremely important) was working as ex-
pected. This structure did not work well in few (6/39)
items where patients failed to distinguish between ‘a
little important’ and ‘fairly important’.
The overall scale (39 items) had an excellent inter-
nal consistency (Cronbach’s Alpha = 0.973). The test
of fit revealed that 35/39 items residuals were within
the expected (2.5) range. All items had a non-signifi-
cant Bonferroni-adjusted Chi-square probability, indi-
cating fit to the model (Table II).
While item-trait Chi-square statistics in table II sug-
gested most of the 39 items fit the Rasch model; an as-
sessment of the residual correlation matrix revealed
significant item-item correlations (>0.3) indicating lo-
cal dependency, which is a violation of the Rasch mo-
del. These locally dependent items were combined into
7 corresponding domains and the ENAT was re-ana-
lysed as a 7-testlet scale, resulting in acceptable fit to
Rasch model expectations (Table III).
Table IV presents the results of a further test of fit,
taking account of person ability (item-person interac-
tion) suggesting initial (39 items) scale deviation from
the Rasch model c2(df) = 56.025 (39), p = 0.038; PSI
= 0.985 (Table IV, analysis 1) and subsequent fit to the
Rasch model following correction for the local depen-
dence (Table IV analysis 2). Analysis 1 is the prelimi-
nary analysis of the 39 items and analysis 2 is the ana-
lysis of the 7-testlet ENAT (having combined indivi-
-adjusted to the alpha level (i.e. p = 0.05/number of
tests carried out). The expected values for perfect mo-
del fit are presented at the bottom of tables of results.
A questionnaire item is required to measure the trait
of interest across different groups of people without
bias. When people from different groups (age, gender,
educational background) with the same level of latent
trait have a different probability of giving a certain res-
ponse on a questionnaire item, the item is said to dis-
play a differential item functioning (DIF)29. DIF was
assessed using the inbuilt facility within RUMM2020
software, which uses a 2-way ANOVA of the person-
-item deviation residuals with person factors (e.g. age
group, country of origin) and class intervals (group
along the trait) as factors. Cross-cultural invariance is
a requirement for questionnaires intended for multi-
national use30,31.The original UK dataset for RA was
pooled with the Portuguese data to assess if PortENAT
had retained its construct validity following its trans-
lation from the original (English) ENAT. The pooled
dataset was also assessed for fit, local dependence and
DIF by culture (cross-cultural DIF).
results
PAtIent chArActerIstIcs
A total of 153 Portuguese patients were recruited in to
this study, 30 for the cross-cultural adaptation phase and
123 for the cross-cultural validation phase. Of the 30 pa-
tients in the adaptation phase, 9 (30%) were male and 21
(70%) women. Their mean age was 51.3 years (range 23,
72) and disease duration 13.9 years (range 2, 35). The
characteristics of patients in the validation phase are sum-
marised in table I. Most of the respondents had a mini-
mum of 11 years of formal education. Those with pri-
mary school education 53 (43.1%), secondary education
28 (22.8%) and university education were 33 (26.8%). 
ADAPTATION INTO PORTUGUESE
In the translation of the ENAT, there were some minor
difficulties associated with two items, one in the ‘fee-
lings’ domain and the other in the ‘arthritis process’
domain. These were solved in the expert committee
meeting carried out by all the translators and health
professionals. In the pilot testing, the adapted version
was well accepted by patients and minor changes in the
treatment domain were needed – ‘appliances’ was
changed to ‘devices or appliances’. No additional ques-
tions were necessary.
tAble I. chArActerIstIcs of Included PAtIents
for VAlIdAtIon PhAse
Characteristics Values
Age, Median (IQR) 52 (43, 60)
Gender, number of women (%) 88 (71.5)
Disease duration, Median (IQR) 12 (7, 18)
Formal education, years (IQR) 14 (11, 18)
Do you want education? (about 118 (95.9)
rheumatoid arthritis) (% yes)
How much information?
Nothing 0 (0)
Some things 21 (17.1)
Lots of things 32 (26.0)
Everything 70 (56.9)
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dual items into their respective domains. The ‘testlet’
solution resulted in an improved scale with better fit
statistics c2(df) = 2.625 (7), p = 0.917 and internal
consistency PSI = 0.975. To allow for cross-cultural in-
variance analysis, the Portugal dataset was pooled to-
gether with the original UK dataset and analysed in the
same procedure described above (Table IV, analysis 1
and analysis 2).
tAble II. IteM test-of-fIt VAlues
Domains Item Location SE Fit residuals DF χ2 *P value
1 -0.982 0.159 0.121 107.090 0.829 0.362
2 -0.472 0.138 0.437 107.090 0.179 0.673
Pain
3 -0.411 0.132 -0.440 107.090 1.455 0.228
4 0.231 0.124 0.768 106.150 0.069 0.792
5 0.379 0.126 1.392 105.210 1.323 0.250
6 0.961 0.110 3.042 107.090 2.382 0.123
7 0.953 0.113 3.135 107.090 2.114 0.146
8 0.521 0.117 2.923 107.090 1.509 0.219
Movement 9 0.164 0.131 0.453 107.090 0.060 0.806
10 -0.046 0.126 0.348 107.090 0.017 0.897
11 -0.055 0.120 2.130 106.150 3.347 0.067
12 0.189 0.135 0.600 107.090 0.055 0.815
Feelings
13 0.342 0.125 -0.745 107.090 2.120 0.145
14 0.359 0.120 -0.913 106.150 0.144 0.704
15 0.379 0.118 -0.971 107.090 0.640 0.424
16 -0.120 0.119 1.355 107.090 0.086 0.770
17 -0.195 0.134 0.161 107.090 2.361 0.124
18 -0.366 0.132 2.209 107.090 0.251 0.616
Disease process 19 -1.514 0.149 -0.978 107.090 0.044 0.834
20 -0.785 0.141 -1.799 106.150 3.731 0.053
21 0.110 0.120 -1.502 107.090 4.305 0.038
22 -0.844 0.141 1.476 107.090 0.007 0.934
23 0.160 0.130 0.585 107.090 3.999 0.046
24 -0.422 0.152 0.256 107.090 0.285 0.593
25 -0.483 0.150 0.308 107.090 0.283 0.595
Treatments 26 0.065 0.131 -0.839 107.090 0.256 0.613
27 0.115 0.131 -1.141 107.090 0.013 0.908
28 0.203 0.124 1.046 107.090 1.408 0.235
29 0.755 0.118 -0.234 107.090 0.406 0.524
30 1.171 0.107 3.762 107.090 10.032 0.002
31 0.079 0.126 0.312 107.090 0.932 0.334
Self-help
32 -0.485 0.136 -0.657 107.090 1.226 0.268
33 -0.450 0.148 -0.938 107.090 1.783 0.182
34 -0.309 0.139 -0.718 107.090 1.988 0.159
35 -0.002 0.139 -0.100 106.150 0.044 0.834
36 0.601 0.130 1.765 107.090 0.072 0.789
Support
37 0.363 0.124 0.436 106.150 0.622 0.430
38 0.816 0.127 0.138 107.090 2.348 0.125
39 -0.973 0.151 -0.561 106.150 3.302 0.069
Expected values for perfect model fit Within ±2.5 >0.05*
DF, degrees of freedom; SE, standard error; *Bonferroni adjusted p-value >0.0013 for model fit (i.e. 0.05/39 tests)
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The pooled dataset was invariant (no DIF) to age,
gender, disease duration and educational background.
Cross-cultural non-invariance (DIF by culture) was pre-
sent on two testlets, ‘treatments’ and ‘support’ where
the Portugal dataset was consistently under-discrimi-
nating and over-discriminating in the latter (Figure 1).
While the PortENAT works with no bias when used
in Portugal, adjustment for the cross-cultural bias is
required if the data from Portugal are pooled or com-
pared with the UK data. Cross-cultural DIF adjust -
ments were undertaken resulting in the ‘adjusted con-
version chart’ (Table V). The conversion chart helps to
transform the raw data, which are at ordinal level into
interval-level data allowing more flexible statistical
analyses and also provides equivalence of measure-
ments when comparing the data from Portugal and the
UK.
dIscussIon
This study used standardised methods for cross-cul-
tural adaptation of outcome measures to develop a Por-
tuguese version of the ENAT (PortENAT). The adap-
tation into Portuguese was seamless, needing no sig-
nificant changes. The translated version (PortENAT)
was well received by patients. Rasch analysis demons-
trated that the construct validity and its measurement
properties were maintained after adaptation process.
Indeed the tool worked without bias across different
groups (gender, age groups, disease duration and edu-
cational backgrounds). However there was DIF on
some items, which is not uncommon in patient-re-
ported outcome measures,11,32,33 and adjustment for
this is required (using the provided conversion table)
in order to ensure accurate estimates when data is com-
tAble III. IndIVIduAl testlet-fIt stAtIstIcs
Testlet Location SE Fit Residuals DF Chi Square *P-value
Pain 0.020 0.036 1.092 92.040 0.175 0.676
Movement -0.056 0.039 1.291 92.860 0.554 0.457
Feelings 0.175 0.042 -1.181 92.860 1.158 0.282
Disease process -0.389 0.033 0.252 92.860 0.096 0.756
Treatments 0.170 0.033 -0.238 93.680 0.080 0.777
Self-Help -0.088 0.037 -0.125 92.860 0.070 0.792
Support 0.169 0.043 1.069 92.860 0.491 0.484
Expected values for perfect model  fit Within ±2.5 >0.05*
DF, degrees of freedom; SE, standard error, *Bonferroni adjusted p-value >0.0071 for model fit (i.e. 0.05/7 tests)
tAble IV. results of rAsch AnAlysIs
Item Fit Person Fit Chi-Square Independent 
Residual Residual Interaction T-Tests 
Country Analysis Mean SD Mean SD Value (DF) p-value* PSI N (95% CI)
Portugal
Analysis 1 0.426 1.355 -0.515 2.624 56.025 (39) 0.038 0.985 114
Analysis 2 0.309 0.901 -0.449 1.337 2.625 (7) 0.917 0.975 114
0.105 (0.065, 0.145)
UK 
Analysis 1 0.340 1.686 -0.269 1.008 71.281 (39) 0.001 0.972 119
Analysis 2 0.541 0.699 -0.308 1.168 7.116 (7) 0.417 0.947 119
0.068 (0.028, 0.107)
Pooled
Analysis 1 0.607 2.188 -0.486 2.472 275.635 (117) <0.001 0.980 233
Analysis 2 0.481 1.137 -0.457 1.352 19.824 (21) 0.532 0.961 233
0.065 (0.037, 0.093)
DIF Adjusted analysis 0.468 1.033 -0.450 1.353 15.860 (27) 0.956 0.962 233
Expected values 0 1 0 1 >0.05 >0.85 Lower bound CI 
for perfect fit <0.05
SD, standard deviation; DF, degrees of freedom; *p-value >0.5 for model fit; PSI, person separation index; Analysis 1, preliminary analysis
with 39 items; Analysis 2, analysis of testlets 
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fIgure 1. Item characteristic curve displaying cross-cultural DIF in ‘treatments’ and ‘support’
tAble V. conVersIon chArt Adjusted for cross-culturAl dIf
Rasch transformed scores
Raw Arthritis UK Support Support 
scores Pain Movement Feelings Treatments Treatments Portugal Self-Help UK Portugal
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1.0 1.1 2.0 1.3 0.8 2.4 0.9 0.6 1.4 1.7
2.0 1.9 3.4 2.2 1.5 4.1 1.5 1.2 2.4 3.0
3.0 2.5 4.4 2.9 2.0 5.3 2.0 1.7 3.3 3.9
4.0 2.8 5.3 3.5 2.4 6.3 2.3 2.3 3.9 4.5
5.0 3.5 6.0 4.1 2.8 7.0 2.6 2.6 4.6 5.2
6.0 4.1 6.8 4.6 3.2 7.7 3.1 3.0 5.3 5.8
7.0 4.5 7.4 5.2 3.6 8.4 3.4 3.6 6.1 6.4
8.0 5.0 8.2 5.8 4.0 9.1 3.6 4.0 7.1 7.0
9.0 5.5 9.0 6.5 4.4 9.8 4.1 4.5 8.1 7.6
10.0 6.1 9.8 7.3 4.8 10.4 4.4 5.1 9.1 8.3
11.0 6.9 10.6 8.2 5.4 11.1 4.9 5.9 10.0 9.0
12.0 7.9 11.4 9.2 6.0 11.8 5.3 7.4 10.9 9.8
13.0 9.2 12.2 10.2 7.0 12.5 5.7 9.4 11.8 10.8
14.0 10.6 13.0 11.6 8.6 13.3 6.5 11.2 12.8 12.0
15.0 11.9 13.8 13.4 10.4 14.0 7.5 12.9 14.2 13.7
16.0 13.2 14.5 16.0 12.3 14.7 8.7 14.3 16.0 16.0
17.0 14.3 15.4 14.1 15.5 9.9 15.5
18.0 15.3 16.5 15.7 16.2 11.2 16.5
19.0 16.3 17.9 17.0 17.0 12.5 17.4
20.0 17.3 20.0 18.2 17.7 13.8 18.4
21.0 18.4 19.2 18.5 15.0 19.4
22.0 19.7 20.1 19.2 16.3 20.6
23.0 21.6 21.0 20.0 17.5 22.1
24.0 24.0 22.0 20.9 18.9 24.0
25.0 23.0 22.0 20.3
26.0 24.4 23.2 22.0
27.0 26.0 25.1 24.6
28.0 28.0 28.0 28.0
The bold columns indicate the adjustment needed if the two countries were to be pooled or compared
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pared or pooled30,34.
This research has validated the PortENAT in RA,
and it can now be used with confidence in the clinical
practice or in patient education research. In the clini-
cal practice, the clinicians can use it as a template to as-
sess patients’ perception of their priority educational
needs and it does not require any scoring. Patients
completing the ENAT have expressed how it enables
them to identify needs which they would not have
other wise considered10,35. The clinician using the ENAT
can then provide the education taking into account of
patient’s perceived needs. This enables the provided
education to be relevant and likely to be more mea-
ningful to patients. The use of PortENAT for research
or audit purposes ensures accurate estimation of the
educational needs of patients with RA. The instruc-
tions of how the PortENAT is used and scored, is pro-
vided in the online supplementary material. The tool
can be obtained by writing to the Psychometric Labo-
ratory at the University of Leeds: http://www.leeds.ac.uk/
medicine/rehabmed/psychometric/index1.htm
The main limitations to this research is that the data
were collected from one rheumatology centre in Por-
tugal and further cross-cultural validation may be re-
quired if PortENAT is to be used in other Portuguese
speaking countries. Secondly, inevitably, the ENAT
items do not cover everything that is known about RA
and future developments will address this limitation by
creating item banking for computerised adaptive as-
sessment, which will ensure more and ‘dynamic’ items
delivered according to need.
A gold standard translation process has been used
to develop a Portuguese version of the Educational
Needs Assessment Tool – PortENAT. Rasch analysis
has confirmed that PortENAT is a robust, 7-subscale
measure of educational needs for people with RA in
Portugal. PortENAT can be used with confidence in
Portugal and cross-cultural comparisons can be un-
dertaken using the calibrated scales.
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coMo utIlIzAr e PontuAr A VersÃo PortuguesA do QuestIonÁrIo 
de AVAlIAÇÃo dAs necessIdAdes educAcIonAIs  (PortenAt)
InforMAÇÃo InIcIAl
O Questionário de Avaliação das Necessidades Educacionais é um questionário auto administrado que contém
39 questões que avaliam as necessidades educacionais dos doentes com artrite reumatóide. As questões estão
agrupadas em 7 domínios ou «super itens» que avaliam aspetos específicos das «necessidades educacionais». Os
itens são: 
1. Gestão da dor
2. Movimento
3. Sentimentos
4. Conhecimentos sobre a artrite
5. Tratamento por profissionais de saúde
6. Medidas de autoajuda
7. Apoio de outros
utIlIzAÇÃo do enAt
O PortENAT pode ser utilizado por profissionais de saúde nas enfermarias ou consultas para avaliar quais as ne-
cessidades educacional/informação prioritárias do ponto de vista do doente. Esta informação, em conjunto com
a percepção do profissional de saúde acerca da informação que o doente precisa, irá permitir uma oferta educa-
cional mais oportuna e significativa, à medida das necessidades individuais de cada doente. 
O PortENAT pode também ser utilizado por investigadores para avaliar as necessidades educacionais dos doen-
tes ao longo do tempo e após uma intervenção educacional. Por exemplo, alterações nas necessidades educacio-
nais podem ser avaliadas comparando os resultados do PortENAT no início e no final de um determinado estudo. 
coMo É Que o PortenAt É PreenchIdo
O PortENAT foi desenhado para ser preenchido pelo doente sozinho. Esta metodologia fornece informações 
objetivas livres de viés. A primeira página fornece informações sobre as características pessoais e uma informação
geral das necessidades educacionais do doente. Esta página não é uma parte integrante do ENAT e cabe ao pro-
fissional de saúde decidir se esta informação é necessária. Por exemplo, pode ser útil para fins de investigação,
mas não para a prática clínica.
Os itens do PortENAT começam na página 2. Cada item é avaliado usando uma escala de Likert de 5 pontos
com os seguintes descritivos: «Nada importante», «Pouco importante», «Bastante importante», «Muito impor-
tante» e «Extremamente importante».
A partir deste momento, o paciente deve colocar um visto “√” na caixa que corresponde ao nível de importân-
cia que atribui em cada pergunta. Apenas uma caixa deve ser assinalada para cada pergunta.
coMo É Que o PortenAt É PontuAdo?
O PortENAT pode ser utilizado na prática clínica como checklist, ou como uma ferramenta de investigação (ou em
auditorias).
PORTENAT UTILIZADO NA PRÁTICA CLÍNICA COMO CHECKLIST
O profissional de saúde pode querer saber qual é o item mais importante para o doente num determinado mo-
mento, permitindo-lhe concentrar-se sobre esse tema durante a sua consulta. Neste caso, as necessidades educa-
cionais prioritárias para o doente podem ser determinadas observando o PortENAT sem a necessidade de pon-
tuar (Exemplo 1).
AneXo
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Exemplo 1: Este item é  relacionado com os seus sentimentos:
PORTENAT UTILIZADO COMO FERRAMENTA DE INVESTIGAÇÃO OU DE AUDITORIA
Para utilização no processo investigação ou de auditoria, o PortENAT precisa ser codificado e pontuado seguin-
do os seguintes passos:
(i) As escalas de Likert do PortENAT devem ser codificadas e pontuadas da seguinte forma:
Nada importante = 0
Pouco importante = 1 
Bastante importante = 2
Muito importante = 3
Extremamente importante  = 4
Ver o exemplo 2 em baixo: 
Exemplo 2: Este item é relacionado com os seus sentimentos:
(i) Após a codificação, as pontuações de cada pergunta são então somadas para fornecer a pontuação do domí-
nio. No exemplo acima, a pontuação do domínio é = 8 (pontuação do domínio sentimentos deve variar en-
tre 0 - 16).
(ii) A pontuação dos domínios obtidos em (i) precisa ser transformada em escala linear, para permitir a sua uti-
lização em análises paramétricas. Isto é feito utilizando a tabela de conversão fornecida abaixo. No exemplo
2 relativo aos sentimentos, a pontuação do domínio bruto de 8, corresponde a uma pontuação do domínio
transformado de 7,7 (Veja a tabela de conversão).
(iii) Somando-se todas as pontuações dos domínios transformados numa escala linear obtém-se a pontuação to-
tal do PortENAT que é uma estimativa das necessidades educacionais dos doentes (variação = 0 -156)
Neste momento, qual é a importância Nada Pouco Bastante Muito Extremamente 
que dá a saber mais sobre o seguinte: importante importante importante importante importante
Maneiras de lidar com o stress √
Maneiras de lidar com as variações 
de humor ou com a depressão √
Porque me sinto cansado(a) √
Porque me sinto em baixo ou deprimido(a) √
Neste momento, qual é a importância Nada Pouco Bastante Muito Extremamente 
que dá a saber mais sobre o seguinte: importante importante importante importante importante
(0) (1) (2) (3) (4)
Maneiras de lidar com o stress √
Maneiras de lidar com as variações de 
humor ou com a depressão √
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tAbelA I. conVersÃo dA PontuAÇÃo dos doMÍnIos eM VAlores obtIdos Por trAnsforMAÇÃo rAsh
Valores obtidos por transformação Rash 
Pontuação 
do domínio Dor Movimento Sentimentos Artrite Tratamento Autoajuda Apoio
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1.0 2.7 1.9 1.8 2.1 2.2 1.5 1.8
2.0 4.5 3.1 3.1 3.6 3.6 2.7 3.0
3.0 5.6 4.1 4.0 4.6 4.6 3.6 4.0
4.0 6.6 4.8 4.8 5.4 5.6 4.3 4.8
5.0 7.3 5.6 5.7 6.2 6.3 5.0 5.5
6.0 8.1 6.2 6.3 6.9 7.1 5.5 6.1
7.0 8.7 6.8 7.0 7.5 7.8 6.1 6.8
8.0 9.3 7.4 7.7 8.2 8.4 6.8 7.5
9.0 9.9 8.1 8.3 8.9 9.1 7.5 8.1
10.0 10.5 8.7 9.0 9.5 9.8 8.2 8.9
11.0 11.1 9.3 9.7 10.3 10.4 9.1 9.6
12.0 11.6 10.0 10.5 11.2 11.3 10.2 10.4
13.0 12.2 10.7 11.4 12.0 12.1 11.3 11.3
14.0 12.8 11.5 12.5 13.0 13.1 12.4 12.3
15.0 13.4 12.3 13.9 13.9 14.1 13.5 13.9
16.0 14.1 13.1 16.0 15.1 14.9 14.4 16.0
17.0 14.6 14.3 15.9 15.9 15.3
18.0 15.3 15.5 16.9 16.7 16.2
19.0 16.1 17.4 17.7 17.4 17.1
20.0 17.0 20.0 18.4 18.2 18.0
21.0 17.9 19.2 19.0 18.9
22.0 19.3 20.0 19.7 20.0
23.0 21.1 20.8 20.5 21.7
24.0 24.0 21.6 21.3 24.0
25.0 22.6 22.3
26.0 23.9 23.7
27.0 25.6 25.3
28.0 28.0 28.0
Preparado por Mwidimi Ndosi & Jackie Hill (2011)
